Picometrix and u2t Introduce CCRx MSA for Fiber Optic Receivers

High-speed optical components companies, Picometrix, LLC, an Advanced Photonix company (NYSE Amex: API) and u²t Photonics AG, have completed the CCRx (Compact Coherent Receiver) multisource agreement (MSA) which defines an industry standard, cost-effective form factor for coherent fiber optic receivers for use in both 100G and 40G DP-QPSK telecommunication systems.

100G CCRx MSA

The MSA provides the receiver form factor, pin function definitions, pin locations, and functionality in a compact optical receiver package designed to enable rapid product development and ease of component procurement for optical transponder and line card manufacturers.

The MSA is now open to component manufacturers interested in joining the CCRx MSA. MSA committee members will be available for scheduled meetings with interested parties at the upcoming OFC/NFOEC conference in San Diego, CA at the end of March. Interested parties should contact the MSA committee through the website www.ccrx-msa.org.

"The release of the CCRx MSA represents a significant milestone to help assist our customers' rapid development and deployment of emerging 100 Gb/s and 40 Gb/s line side equipment," said the MSA Committee. "Our goal is to enable cost-effective, high-performance components, initially for 100G applications and then subsequently for 40G coherent applications."

Picometrix and u2t are both contributing members of the 100G Long Distance DWDM Integrated Photonics working group within the Optical Internetworking Forum (OIF), a catalyst for fostering industry standards. The MSA is intended to be compatible with any forthcoming OIF 100G optical receiver implementation agreement.

Both companies will be exhibiting at OFC/NFOEC, the world?s largest optical communications event, in San Diego, California from March 23-25, 2010. Each company will have their CCRx MSA products on display, Picometrix in booth #921 and u2t in booth #1312.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.